ResearcherTianjin Medical UniversityNo recent work listed

Shuai Leng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-9938-1038; OpenAlex author ID A5079206152. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 2 papers

Papers 2

SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Co-author DOI 10.1038/s41418-021-00821-z ↗
[CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1]. First author DOI 10.3760/cma.j.cn112152-20210108-00030 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yan Wang · 2 shared papers, 2021 · strength 0.34
- Paper [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1]. DOI 10.3760/cma.j.cn112152-20210108-00030 ↗
- Paper SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. DOI 10.1038/s41418-021-00821-z ↗
Yue Chen · 1 shared paper, 2021 · strength 0.22
- Paper [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1]. DOI 10.3760/cma.j.cn112152-20210108-00030 ↗
Wei Liu · 1 shared paper, 2021 · strength 0.12
- Paper SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. DOI 10.1038/s41418-021-00821-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.